Developing a robust two-step machine learning multiclassification pipeline to predict primary site in head and neck carcinoma from lymph nodes.

Head and neck carcinoma of unknown primary Machine learning Multiclassification Radiomics

Journal

Heliyon
ISSN: 2405-8440
Titre abrégé: Heliyon
Pays: England
ID NLM: 101672560

Informations de publication

Date de publication:
30 Jan 2024
Historique:
received: 01 08 2023
revised: 22 12 2023
accepted: 08 01 2024
medline: 5 2 2024
pubmed: 5 2 2024
entrez: 5 2 2024
Statut: epublish

Résumé

This study aimed to develop a robust multiclassification pipeline to determine the primary tumor location in patients with head and neck carcinoma of unknown primary using radiomics and machine learning techniques. The dataset included 400 head and neck cancer patients with primary tumor in oropharynx, OPC (n = 162), nasopharynx, NPC (n = 137), oral cavity, OC (n = 63), larynx and hypopharynx, HL (n = 38). Two radiomic-based multiclassification pipelines (P1 and P2) were developed. P1 consisted in a direct identification of the primary sites, whereas P2 was based on a two-step approach: in the first step, the number of classes was reduced by merging the two minority classes which were reclassified in the second step. Diverse correlation thresholds (0.75, 0.80, 0.85), feature selection methods (sequential forwards/backwards selection, sequential floating forward selection, neighborhood component analysis and minimum redundancy maximum relevance), and classification models (neural network, decision tree, naïve Bayes, bagged trees and support vector machine) were assessed. P2 outperformed P1, with the best results obtained with the support vector machine classifier including radiomic and clinical features (accuracies of 75.3 % (HL), 75.4 % (OC), 71.3 % (OPC), 92.9 % (NPC)). These results indicate that the two-step multiclassification pipeline integrating radiomics and clinical information is a promising approach to predict the tumor site of unknown primary.

Identifiants

pubmed: 38312621
doi: 10.1016/j.heliyon.2024.e24377
pii: S2405-8440(24)00408-0
pmc: PMC10835257
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e24377

Informations de copyright

© 2024 The Authors.

Déclaration de conflit d'intérêts

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Jiaying Liu (J)

Department of Electronics, Information and Bioengineering, Politecnico di Milano, Milan, Italy.

Anna Corti (A)

Department of Electronics, Information and Bioengineering, Politecnico di Milano, Milan, Italy.

Giuseppina Calareso (G)

Radiology Department, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.

Gaia Spadarella (G)

Postgraduation School in Radiodiagnostics, University of Milan, Italy.
Department of Clinical Medicine and Surgery, Federico II University, Naples, Italy.

Lisa Licitra (L)

Head and Neck Cancer Medical Oncology Department, Fondazione IRCCS Instituto Nazionale dei Tumori di Milano, Milan, Italy.
Department of Oncology and Hemato-Oncology, University of Milan, Italy.

Valentina D A Corino (VDA)

Department of Electronics, Information and Bioengineering, Politecnico di Milano, Milan, Italy.
Cardiotech Lab, Centro Cardiologico Monzino IRCCS, Milan, Italy.

Luca Mainardi (L)

Department of Electronics, Information and Bioengineering, Politecnico di Milano, Milan, Italy.

Classifications MeSH